Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Idrugs : the Investigational Drugs Journal|February 8, 2005
Focus on deacetylation for therapeutic benefitShabana Shabbeer, Michael A CarducciClinical Biochemistry|February 7, 2012
Normal range of serum Amphiregulin in healthy adult human femalesEsther A Peterson, Shabana Shabbeer, Paraic A KennyCancer Prevention Research (Philadelphia, Pa.)|December 6, 2011
Progression of prostate carcinogenesis and dietary methyl donors: temporal dependenceShabana Shabbeer, Simon A Williams, Brian W Simons, et al.The International Journal of Biochemistry & Cell Biology|June 30, 2012
BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrestRonit I Yarden, Sally Metsuyanim, Itay Pickholtz, et al.The Prostate|May 5, 2007
Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivoShabana Shabbeer, Madeleine S Q Kortenhorst, Sushant Kachhap, et al.Experimental Hematology & Oncology|September 10, 2013
Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controlsEsther A Peterson, Eirini Pectasides, Shabana Shabbeer, et al.BMC Bioinformatics|May 3, 2007
Pre-processing Agilent microarray dataMarianna Zahurak, Giovanni Parmigiani, Wayne Yu, et al.Cancer Research|July 20, 2006
Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivoQinghua Xia, Jennifer Sung, Wasim Chowdhury, et al.Journal of Biomedicine & Biotechnology|October 25, 2012
Mechanism of growth inhibition of prostate cancer xenografts by valproic acidAbhinav Sidana, Muwen Wang, Shabana Shabbeer, et al.Journal of Biomedicine & Biotechnology|October 29, 2010
Does valproic acid induce neuroendocrine differentiation in prostate cancer?Abhinav Sidana, Muwen Wang, Wasim H Chowdhury, et al.Pageof 2